Management of the myeloproliferative disorders: distinguishing data from dogma

被引：13

作者：

Green, AR ^{[1
]}

Vassiliou, GS ^{[1
]}

Curtin, N ^{[1
]}

Campbell, PJ ^{[1
]}

机构：

[1] Univ Cambridge, Dept Haematol, Cambridge, England

来源：

HEMATOLOGY JOURNAL | 2004年 / 5卷

基金：

英国惠康基金;

关键词：

D O I：

10.1038/sj.thj.6200438

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S126 / S132

页数：7

共 21 条

[1] Major vascular complications in essential thrombocythemia:: a study of the predictive factors in a series of 148 patients [J].

Besses, C ;

Cervantes, F ;

Pereira, A ;

Florensa, L ;

Solé, F ;

Hernández-Boluda, C ;

Woessner, S ;

Sans-Sabrafen, J ;

Rozman, C ;

Montserrat, E .

LEUKEMIA, 1999, 13 (02) :150-154

[2] HYDROXYUREA FOR PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND A HIGH-RISK OF THROMBOSIS [J].

CORTELAZZO, S ;

FINAZZI, G ;

RUGGERI, M ;

VESTRI, O ;

GALLI, M ;

RODEGHIERO, F ;

BARBUI, T .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) :1132-1136

[3] INCIDENCE AND RISK-FACTORS FOR THROMBOTIC COMPLICATIONS IN A HISTORICAL COHORT OF 100 PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA [J].

CORTELAZZO, S ;

VIERO, P ;

FINAZZI, G ;

DEMILIO, A ;

RODEGHIERO, F ;

BARBUI, T .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :556-562

[4] Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial [J].

Finazzi, G ;

Ruggeri, M ;

Rodeghiero, F ;

Barbui, T .

BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) :577-583

[5] Acquired DNA mutations associated with in vivo hydroxyurea exposure [J].

Hanft, VN ;

Fruchtman, SR ;

Pickens, CV ;

Rosse, WF ;

Howard, TA ;

Ware, RE .

BLOOD, 2000, 95 (11) :3589-3593

[6] Essential thrombocythemia [J].

Harrison, CN ;

Green, AR .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (05) :1175-+

[7]

IMBERT M, 2001, WHO CLASSIFICATION T, P39

[8] Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders [J].

Kralovics, R ;

Buser, AS ;

Teo, SS ;

Coers, J ;

Tichelli, A ;

van der Maas, APC ;

Skoda, RC .

BLOOD, 2003, 102 (05) :1869-1871

[9] Efficacy and safety of low-dose aspirin in polycythemia vera [J].

Landolfi, R ;

Marchioli, R ;

Kutti, J ;

Gisslinger, H ;

Tognoni, G ;

Patrono, C ;

Barbui, T ;

Landolfi, R ;

Marchioli, R ;

Kutti, J ;

Gisslinger, H ;

Tognoni, G ;

Patrono, C ;

Barbui, T ;

Gisslinger, H ;

Barbui, T ;

Finazzi, G ;

Pusterla, S ;

Falanga, A ;

Galli, M ;

Kutti, J ;

Wadenvik, H ;

Gastl, G ;

Ludescher, C ;

Lutz, D ;

Girschikofsky, M ;

Michlmayr, G ;

Rechberger, E ;

Niessner, H ;

Ivansich, E ;

Rain, JD ;

Chommienne-Thomas, C ;

Hehlmann, R ;

Engelich, G ;

Kohne, E ;

Kramer, A ;

Christakis, JI ;

Papaioannou, M ;

Gerotziafas, G ;

O'Donnell, R ;

Bennett, M ;

Lugassy, G ;

Ellis, M ;

Eldor, A ;

Naparstek, E ;

Marilus, R ;

Leoni, P ;

Rupoli, S ;

Scortechini, AR ;

Agostini, V .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (02) :114-124

[10]

Najean Y, 1997, SEMIN HEMATOL, V34, P6

← 1 2 3 →